Acute haemodynamic effects of endralazine in patients with coronary artery disease and stable angina pectoris.


The acute haemodynamic effects of endralazine, a new hydralazine-like vasodilating agent, were studied in 6 patients with stable angina pectoris and proven coronary artery disease. Twenty minutes after intravenous administration of 5 mg endralazine heart rate and cardiac index increase, while mean arterial blood pressure and total systemic resistance were… (More)


  • Presentations referencing similar topics